Published • loading... • Updated
Biogen (BIIB) Stock Surges to 52-Week Peak After BlackRock's $3.4B Investment
Summary by Blockonomi
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Biogen (BIIB) Stock Surges to 52-Week Peak After BlackRock's $3.4B Investment
Key Highlights Biogen shares reached a 52-week peak at $219.94, climbing 57% year-over-year Second-quarter revenue totaled $2.74 billion, surpassing Wall Street’s $2.46 billion projection Earnings per share of $3.60 exceeded analyst consensus of $2.94 Company upgraded 2026 revenue forecast to mid-single-digit growth from previous decline BlackRock acquired 15.98 million shares worth approximately $3.45 billion Shares of Biogen (BIIB) surged to …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
